3-溴喹啉-6-胺 | 7101-96-4

• 物质功能分类: 医药中间体 - 杂环化合物 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 3-溴喹啉-6-胺
• 中文别名: 6-氨基-3-溴喹啉
• 英文名称: 3-Brom-6-amino-chinolin
• 英文别名: 6-Amino-3-brom-chinolin；3-bromo-quinolin-6-ylamine；3-bromo-[6]quinolylamine；3-Brom-[6]chinolylamin；6-amino-3-bromo-quinoline；3-bromo-6-aminoquinoline；3-Bromoquinolin-6-amine
• CAS: 7101-96-4
• 化学式: C₉H₇BrN₂
• mdl: MFCD07757603
• 分子量: 223.072
• InChiKey: XOXNGIYWQRRRPW-UHFFFAOYSA-N

物化性质

• 熔点：
  154-155 ºC
• 沸点：
  359.0±22.0 °C(Predicted)
• 密度：
  1.649

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933499090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromoquinolin-6-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromoquinolin-6-amine
CAS number: 7101-96-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H7BrN2
Molecular weight: 223.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴喹啉-6-胺 在 磷酸 、 间氯过氧苯甲酸 作用下， 以 乙醇 、 水 为溶剂， 反应 72.0h， 生成 3-Bromo-1-oxidoquinolin-1-ium-6-ol
  参考文献：
  名称：

  2,2,3-Tribromopropanal as a Versatile Reagent in the Skraup-Type Synthesis of 3-Bromoquinolin-6-ols

  摘要：

  2,2,3-Tribromopropanal, a reagent which almost became forgotten in the chemical literature after its first application in the 1950s, is used for the one-step transformation of diversely substituted 4-nitro- and 4-methoxyanilines into 3-bromo-6-nitroquinolines and 3-bromo-6-methoxyquinolines. These intermediates are then converted, in one further step, into 3-bromoquinolin-6-ols, which may carry additional substituents at positions 7 and 8.

  DOI：

  10.1055/s-0033-1340670
• 作为产物：
  描述：

  3-溴-6-硝基喹啉 在 铁粉 、 溶剂黄146 作用下， 生成 3-溴喹啉-6-胺
  参考文献：
  名称：

  Claus; Schnell, Journal fur praktische Chemie (Leipzig 1954), 1896, vol. <2> 53, p. 112

  摘要：

  DOI：

文献信息

• [EN] QUINOLIN-, ISOQUINOLIN-, AND QUINAZOLIN-OXYALKYLAMIDES AND THEIR USE AS FUNGICIDES<br/>[FR] OXYALKYLAMIDES DE QUINOLINE, D'ISOQUINOLINE ET DE QUINAZOLINE ET LEUR UTILISATION COMME FONGICIDES
  申请人：SYNGENTA LTD

  公开号：WO2004047538A1

  公开（公告）日：2004-06-10

  Fungicidal compounds of the general formula (1) wherein one of X and Y is N or N-oxide and the other is CR or both of X and Y are N.

  通用公式（1）中的杀真菌化合物，其中X和Y中的一个是N或N-氧化物，另一个是CR，或者X和Y都是N。
• [EN] NOVEL BICYCLIC ANTIBIOTICS<br/>[FR] NOUVEAUX ANTIBIOTIQUES BICYCLIQUES
  申请人：BASILEA PHARMACEUTICA AG

  公开号：WO2010084152A1

  公开（公告）日：2010-07-29

  Compounds of formula (I) wherein X1, X3; X4 and X6, each independently of the others, represents a nitrogen atom or CR2, with the proviso that at least one of X1, X3; X4 and X6 represents a nitrogen atom; X2 represents C-H, C-(C1-C6alkyl), C-(C1-C6alkoxy), C-halogen, C-COOH; X5 represents C-H or C-(C1-C6alkyl), C-halogen; R1 and R2, independently of one another, represent hydrogen or a substituent selected from hydroxy, halogen, carboxy, amino, C1-C6alkylamino, di(C1-C6alkyl)amino, mercapto, cyano, nitro, C1-C6alkyl, C1-C6alkoxy, C1-C6alkylthio, C1-C6alkylamino- carbonyloxy, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkylcarbonyloxy, C1-C6alkyl- sulfonyloxy, C1 -C6heteroalkylcarbonyloxy, C5-C6heterocyclylcarbonyloxy, C1-C6heteroalkyl, C1-C6heteroalkoxy, wherein heteroalkyl, heteroalkoxy groups or heterocyclyl comprise 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, in which substituents the alkyl moieties are unsubstituted or further substituted by halogeno, cyano, hydroxy, C1-C4alkoxy, C1-C4alkylcarbonyl, C1-C4alkoxycarbonyl, unsubstituted or substituted phenoxy or phenylcarbonyl, unsubstituted or substituted C5-C6heterocyclyl or carboxy; A1 represents a divalent group of one of the formulae -O-(CH2)m-(CH2)-, -S-(CH2)m-(CH2)- or -(C=O)O-(CH2)m-(CH2)-, wherein the (CH2)m moiety is optionally substituted by C1-C4alkyl, C2-C4alkenyl, C3-C6cycloalkyl, C3-C6cycloalkylmethyl, morpholinomethyl, halogen, carboxy, hydroxy, C1-C4alkoxy; C1 -C4alkoxyC1 -C4alkyl, C1 -C4alkoxy(C1 -C4alkylenoxy)C1 -C4alkyl, benzyloxyC1 - C4alkyl, amino, mono- or di-(C1-C4alkyl)amino or acylamino, in which substituents the alkyl moieties can be further substituted by 1 or more fluoro atoms m is 0, 1 or 2, provided that the number of atoms in the direct chain between the two terminal valencies of A1 is at least 3, which group A1 is linked to A2 via the terminal (CH2)-moiety; A2 is a group selected from C3-C8cycloalkylene; saturated and unsaturated 4 to 8- membered heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, which group A2 is unsubstituted or substituted; R4 represents hydrogen or C1 -C4alkyl; A3 represents C1-C4alkylene, C2-C4alkenylene, >C=O, -C(O)C1-C3alkylene-, -C(=O)NH-, or a group selected from -C2H4NH-, -C2H4O-, and -C2H4S- being linked to the adjacent NR4-group via the carbon atom; and G represents aryl or heteroaryl, which is unsubstituted or substituted and n is 0, 1 or 2; or a pharmaceutically acceptable salts, hydrates or solvates thereof are valuable antibacterial agents.

  式(I)中的化合物，其中X1、X3、X4和X6，每个独立地代表氮原子或CR2，但X1、X3、X4和X6中至少有一个代表氮原子；X2代表C-H、C-(C1-C6烷基)、C-(C1-C6烷氧基)、C-卤素、C-COOH；X5代表C-H或C-(C1-C6烷基)、C-卤素；R1和R2独立地代表氢或从羟基、卤素、羧基、氨基、C1-C6烷基氨基、二(C1-C6烷基)氨基、巯基、氰基、硝基、C1-C6烷基、C1-C6烷氧基、C1-C6烷硫基、C1-C6烷基氧基羰氧、C2-C6烯基、C2-C6炔基、C1-C6烷基羰氧、C1-C6烷基磺酰氧、C1-C6杂烷基羰氧、C5-C6杂环烷基羰氧、C1-C6杂烷基、C1-C6杂烷氧基中选择的取代基；A1代表以下式之一的二价基团：-O-(CH2)m-(CH2)-、-S-(CH2)m-(CH2)-或-(C=O)O-(CH2)m-(CH2)-，其中(CH2)m基团可选择地由C1-C4烷基、C2-C4烯基、C3-C6环烷基、C3-C6环烷基甲基、吗啉基甲基、卤素、羧基、羟基、C1-C4烷氧基；C1-C4烷氧基C1-C4烷基、C1-C4烷氧基(C1-C4烷氧基)C1-C4烷基、苄氧基C1-C4烷基、氨基、单或二-(C1-C4烷基)氨基或酰胺基取代，其中取代基的烷基基团可以进一步由1个或多个氟原子取代；m为0、1或2，前提是A1的两个末端价的直链中的原子数至少为3，该基团A1通过末端(CH2)-基团与A2连接；A2是选择自C3-C8环烷基烯；饱和和不饱和的含氮、氧和硫的1、2或3个杂原子的4至8环杂环二基团，该基团A2未取代或取代；R4代表氢或C1-C4烷基；A3代表C1-C4亚烷基、C2-C4烯亚烷基、>C=O、-C(O)C1-C3烷基-、-C(=O)NH-，或选择自-C2H4NH-、-C2H4O-和-C2H4S-的基团，通过碳原子与相邻的NR4基团连接；G代表芳香族或杂芳基，未取代或取代，n为0、1或2；或其药学上可接受的盐、水合物或溶剂合物是有价值的抗菌剂。
• Quinolin-,isoquinolin-,and quinazolin-oxyalkylamides and their use as fungicides
  申请人：Salmon Roger

  公开号：US20060019973A1

  公开（公告）日：2006-01-26

  Fungicidal compounds of the general formula (1) wherein one of X and Y is N or N-oxide and the other is CR or both of X and Y are N.

  通式（1）的杀真菌化合物，其中X和Y中的一个是N或N-氧化物，另一个是CR，或者X和Y都是N。
• QUINOLIN-ISOQUINOLIN-AND QUINAZOLIN-OXYALKYLAMIDES AND THEIR USE AS FUNGICIDES
  申请人：CROWLEY Jelf Patrick

  公开号：US20070072884A1

  公开（公告）日：2007-03-29

  Fungicidal compounds of the general formula (1): wherein one of X and Y is N or N-oxide and the other is CR or both of X and Y are N; Z is H, halo, C 1-6 alkyl optionally substituted with halo or C 1-4 alkoxy, C 3-6 cycloalkyl optionally substituted with halo or C 1-4 alkoxy, C 2-4 alkenyl optionally substituted with halo, C 2-4 alkynyl optionally substituted with halo, C 1-6 alkoxy optionally substituted with halo or C 1-4 alkoxy, C 2-4 alkenyloxy optionally substituted with halo, C 2-4 alkynyloxy optionally substituted with halo, cyano, nitro, C 1-4 alkoxycarbonyl, —OSO 2 R′, S(O) n R′, —COR″, —CONR″R′″, —CR″═NOR′, NR″R″′, NR″COR′, NR″CO 2 R′ where n is 0, 1 or 2, R′ is C 1-6 alkyl optionally substituted with halogen and R″ and R′″ are independently H or C 1-6 alkyl or, in the case of —CONR″R′″, may join to form a 5- or 6-membered ring containing a single nitrogen atom, saturated carbon atoms and optionally a single oxygen atom; R is H, halo, C 1-8 alkyl, C 3-6 cycloalkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 1-8 alkoxy, C 1-8 alkylthio, nitro, amino, mono- or di-(C 1-6 )alkylamino, mono- or di-(C 2-6 )alkenyl-amino, mono- or di-(C 2-6 )alkynylamino, formylamino, C 1-4 alkyl(formyl)amino, C 1-4 alkylcarbonylamino, C 1-4 alkoxycarbonylamino, C 1-4 alkyl(C 1-4 alkyl-carbonyl)amino, cyano, formyl, C 1-4 alkylcarbonyl, C 1-4 alkoxycarbonyl, amino-carbonyl, mono- or di-(C 1-4 )alkylaminocarbonyl, carboxy, C 1-4 alkylcarbonyloxy, aryl(C 1-4 )alkylcarbonyloxy, C 1-4 alkylsulphinyl, C 1-4 alkylsulphonyl or C 1-4 alkyl-sulphonyloxy; R 1 is C 1-4 alkyl, C 2-4 alkenyl or C 2-4 alkynyl in which the alkyl, alkenyl and alkynyl groups are optionally substituted on their terminal carbon atom with one, two or three halogen atoms, with a cyano group, with a C 1-4 alkylcarbonyl group, with a C 1-4 alkoxycarbonyl group or with a hydroxy group, or R 1 is alkoxyalkyl, alkylthioalkyl, alkylsulphinylalkyl or alkylsulphonylalkyl in which the total number of carbon atoms is 2 or 3, or R 1 is a straight-chain C 1-4 alkoxy group; R 2 is H, C 1-4 alkyl, C 1-4 alkoxymethyl or benzyloxymethyl in which the phenyl ring of the benzyl moiety is optionally substituted with C 1-4 alkoxy; R 3 and R 4 are independently H, C 1-3 alkyl, C 2-3 alkenyl or C 2-3 alkynyl provided that both are not H and that when both are other than H their combined total of carbon atoms does not exceed 4, or R 3 and R 4 join with the carbon atom to which they are attached to form a 3 or 4 membered carbocyclic ring optionally containing one O, S or N atom and optionally substituted with halo or C 1-4 alkyl; and R 5 is H, C 1-4 alkyl or C 3-6 cycloalkyl in which the alkyl or cycloalkyl group is optionally substituted with halo, hydroxy, C 1-6 alkoxy, cyano, C 1-4 alkylcarbonyloxy, aminocarbonyloxy, mono- or di(C 1-4 )alkylaminocarbonyloxy, —S(O) n (C 1-6 )-alkyl where n is 0, 1 or 2, triazolyl (e.g. 1,2,4-triazol-1-yl), tri(C 1-4 )alkylsilyloxy, optionally substituted phenoxy, optionally substituted thienyloxy, optionally substituted benzyloxy or optionally substituted thienylmethoxy, or R 5 is optionally substituted phenyl, optionally substituted thienyl or optionally substituted benzyl, in which the optionally substituted phenyl and thienyl rings of the R 5 values are optionally substituted with one, two or three substituents selected from halo, hydroxy, mercapto, C 1-4 alkyl, C 2-4 , alkenyl, C 2-4 alkynyl, C 1-4 alkoxy, C 2-4 alkenyloxy, C 2-4 alkynyloxy, halo (C 1-4 )alkyl, halo(C 1-4 )alkoxy, C 1-4 alkylthio, halo(C 1-4 )alkylthio, hydroxy(C 1-4 )alkyl, C 1-4 alkoxy(C 1-4 )alkyl, C 3-6 cycloalkyl, C 3-6 cycloalkyl(C 1-4 )alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR m R n , —NHCOR m , —NHCONR m R n , —CONR m R n , —SO 2 R m , —OSO 2 R m , —COR m , —CR m ═NR n or —N═CR m R n , in which R m and R n are independently hydrogen, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy, halo-(C 1-4 )alkoxy, C 1-4 alkylthio, C 3-6 cycloalkyl, C 3-6 cycloalkyl(C 1-4 )alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C 1-4 alkyl or C 1-4 alkoxy.

  一般式（1）的杀真菌化合物： 其中X和Y中的一个是N或N-氧化物，另一个是CR，或者X和Y都是N； Z是H，卤素，C1-6烷基（可选择卤素或C1-4氧烷基），C3-6环烷基（可选择卤素或C1-4氧烷基），C2-4烯基（可选择卤素），C2-4炔基（可选择卤素），C1-6氧烷基（可选择卤素或C1-4氧烷基），C2-4烯氧基（可选择卤素），C2-4炔氧基（可选择卤素），氰基，硝基，C1-4氧羰基，-OSO2R′，S（O）nR′，-COR″，-CONR″R′″，-CR″═ NOR′，NR″R″′，NR″COR′，NR″CO2R′，其中n为0、1或2，R′为C1-6烷基（可选择卤素取代），R″和R′″独立地为H或C1-6烷基，或在-CONR″R′″的情况下，它们可以结合形成含有单个氮原子、饱和碳原子和可选择单个氧原子的5-或6元环； R为H，卤素，C1-8烷基，C3-6环烷基，C2-8烯基，C2-8炔基，C1-8氧烷基，C1-8烷基硫基，硝基，氨基，单或双（C1-6）烷基氨基，单或双（C2-6）烯基氨基，单或双（C2-6）炔基氨基，甲酰氨基，C1-4烷基（甲酰）氨基，C1-4烷基羰基氨基，C1-4氧烷基羰基氨基，C1-4烷基（C1-4烷基-羰基）氨基，氰基，甲酰基，C1-4烷基羰基，C1-4氧烷基羰基，氨基羰基，单或双（C1-4）烷基氨基羰基，羧基，C1-4烷基羧酸酯，芳基（C1-4）烷基羧酸酯，C1-4烷基磺基，C1-4烷基磺酰基或C1-4烷基磺酰氧基； R1为C1-4烷基、C2-4烯基或C2-4炔基，其中烷基、烯基和炔基基团在其末端碳原子上可以选择地取代一个、两个或三个卤素原子、一个氰基、一个C1-4烷基羰基基团、一个C1-4氧烷基羰基基团或一个羟基，或R1为烷氧基烷基、烷基硫基烷基、烷基磺基烷基或烷基磺酰基烷基，其中碳原子的总数为2或3，或R1为直链C1-4烷氧基； R2为H，C1-4烷基，C1-4氧甲基或苄氧甲基，其中苄基部分的苯环可以选择地用C1-4氧烷基取代； R3和R4独立地为H，C1-3烷基，C2-3烯基或C2-3炔基，前提是两者都不是H，且当两者都不是H时，它们的碳原子总数不超过4，或R3和R4与它们附着的碳原子结合形成一个3或4元环烷基，可选择地含有一个O、S或N原子，并可选择地用卤素或C1-4烷基取代； R5为H，C1-4烷基或C3-6环烷基，其中烷基或环烷基基团可选择地用卤素、羟基、C1-6氧烷基、氰基、C1-4烷基羧酸酯、氨基羧酸酯、单或双（C1-4）烷基氨基羧酸酯、-S（O）n（C1-6）-烷基（n为0、1或2）、三唑基（例如1,2,4-三唑基）、三（C1-4）烷基硅氧烷基、可选择地取代的苯氧基、可选择地取代的噻吩氧基、可选择地取代的苄氧基或可选择地取代的噻吩基甲氧基，或R5为可选择地取代的苯基、可选择地取代的噻吩基或可选择地取代的苄基，其中R5的可选择取代的苯基和噻吩基环可选择地用一个、两个或三个取代基取代，所述取代基选自卤素、羟基、巯基、C1-4烷基、C2-4烯基、C2-4炔基、C1-4氧烷基、C2-4烯氧基、C2-4炔氧基、卤素（C1-4）烷基、卤素（C1-4）氧烷基、C1-4烷基硫基、卤素（C1-4）烷基硫基、羟基（C1-4）烷基、C1-4氧烷基（C1-4）烷基、C3-6环烷基、C3-6环烷基（C1-4）烷基、苯氧基、苄氧基、苯甲酰氧基、氰基、异氰酸基、硫氰酸基、异硫氰酸基、硝基、-NRmRn，-NHCORm，-NHCONRmRn，-CONRmRn，-SO2Rm，-OSO2Rm，-CORm，-CRm═NRn或-N═CRmRn，其中Rm和Rn独立地为氢、C1-4烷基、卤素（C1-4）烷基、C1-4氧烷基、卤素（C1-4）氧烷基、C1-4烷基硫基、C3-6环烷基、C3-6环烷基（C1-4）烷基、苯基或苄基，所述苯基和苄基可选择地取代卤素、C1-4烷基或C1-4氧烷基。
• Novel Bicyclic Antibiotics
  申请人：Gaucher Berangere

  公开号：US20120040957A1

  公开（公告）日：2012-02-16

  Compounds of formula (I) wherein X1, X3; X4 and X6, each independently of the others, represents a nitrogen atom or CR2, with the proviso that at least one of X1, X3; X4 and X6 represents a nitrogen atom; X2 represents C—H, C—(C1-C6alkyl), C—(C1-C6alkoxy), C-halogen, C—COOH; X5 represents C—H or C—(C1-C6alkyl), C-halogen; R1 and R2, independently of one another, represent hydrogen or a substituent selected from hydroxy, halogen, carboxy, amino, C1-C6alkylamino, di(C1-C6alkyl)amino, mercapto, cyano, nitro, C1-C6alkyl, C1-C6alkoxy, C1-C6alkylthio, C1-C6alkylamino-carbonyloxy, C2-C6alkenyl, C2-C6alkynyl, C1-C6alkylcarbonyloxy, C1-C6alkyl-sulfonyloxy, C1-C6heteroalkylcarbonyloxy, C5-C6heterocyclyl-carbonyloxy, C1-C6heteroalkyl, C1-C6heteroalkoxy, wherein heteroalkyl, heteroalkoxy groups or heterocyclyl comprise 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, in which substituents the alkyl moieties are unsubstituted or further substituted by halogeno, cyano, hydroxy, C1-C4alkoxy, C1-C4alkylcarbonyl, C1-C4alkoxycarbonyl, unsubstituted or substituted phenoxy or phenylcarbonyl, unsubstituted or substituted C5-C6heterocyclyl or carboxy; A1 represents a divalent group of one of the formulae —O—(CH 2 ) m —(CH 2 )—, —S—(CH 2 ) m —(CH 2 )— or —(C═O)O—(CH 2 ) m —(CH 2 )—, wherein the (CH 2 ) m moiety is optionally substituted by C1-C4alkyl, C2-C4alkenyl, C3-C6cycloalkyl, C3-C6cycloalkylmethyl, morpholinomethyl, halogen, carboxy, hydroxy, C1-C4alkoxy; C1-C4alkoxyC1-C4alkyl, C1-C4alkoxy(C1-C4alkylenoxy)C1-C4alkyl, benzyloxyC1-C4alkyl, amino, mono- or di-(C1-C4alkyl)amino or acylamino, in which substituents the alkyl moieties can be further substituted by 1 or more fluoro atoms m is 0, 1 or 2, provided that the nunber of atoms in the direct chain between the two terminal valencies of A 1 is at least 3, which group A 1 is linked to A 2 via the terminal (CH 2 )-moiety; A 2 is a group selected from C 3 -C 8 cycloalkylene; saturated and unsaturated 4 to 8 -membered heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, which group A 2 is unsubstituted or substituted; R 4 represents hydrogen or C 1 -C 4 alkyl; A 3 represents C 1 -C 4 alkylene, C 2 -C 4 alkenylene, >C═O, —C(O)C 1 -C 3 alkylene-, —C(═O)NH—, or a group selected from —C 2 H 4 NH—, —C 2H 4 O—, and —C 2 H 4 S— being linked to the adjacent NR 4 -group via the carbon atom; and G represents aryl or heteroaryl, which is unsubstituted or substituted and n is 0, 1 or 2; or a pharmaceutically acceptable salts, hydrates or solvates thereof are valuable antibacterial agents.

  化合物式(I)中，其中X1、X3、X4和X6分别独立地表示氮原子或CR2，但至少其中一个表示氮原子；X2表示C-H、C-(C1-C6烷基)、C-(C1-C6烷氧基)、C-卤素、C-COOH；X5表示C-H或C-(C1-C6烷基)、C-卤素；R1和R2独立地表示氢或从羟基、卤素、羧基、氨基、C1-C6烷基氨基、二(C1-C6烷基)氨基、巯基、氰基、硝基、C1-C6烷基、C1-C6烷氧基、C1-C6烷基硫基、C1-C6烷基氨基羰氧基、C2-C6烯基、C2-C6炔基、C1-C6烷基羰氧基、C1-C6烷基磺酰氧基、C1-C6杂烷基羰氧基、C5-C6杂环基羰氧基、C1-C6杂烷基、C1-C6杂烷氧基中选择的取代基，其中杂烷基、杂烷氧基或杂环基包括1、2或3个从氮、氧和硫选择的杂原子，在这些取代基中，烷基基团未取代或进一步取代为卤代、氰基、羟基、C1-C4烷氧基、C1-C4烷基羧基、C1-C4烷氧羰基、未取代或取代的苯氧基或苯基羧基、未取代或取代的C5-C6杂环基或羧基；A1表示一个二价基团，其中之一为式之一的基团-O-(CH2)m-(CH2)-、-S-(CH2)m-(CH2)-或-(C═O)O-(CH2)m-(CH2)-，其中(CH2)m基团可以选择地被C1-C4烷基、C2-C4烯基、C3-C6环烷基、C3-C6环烷基甲基、吗啉基甲基、卤素、羧基、羟基、C1-C4烷氧基取代；C1-C4烷氧基C1-C4烷基、C1-C4烷氧基(C1-C4烷氧基)C1-C4烷基、苄氧基C1-C4烷基、氨基、单取代或双取代(C1-C4烷基)氨基或酰基氨基，在这些取代基中，烷基基团可以进一步取代1个或多个氟原子，m为0、1或2，前提是A1的两个端面价之间的直链原子数至少为3，该基团A1通过端面(CH2)基团与A2相连；A2是选择自C3-C8环烷基、饱和和不饱和的1、2或3个从氮、氧和硫选择的杂环二基，该基团A2未取代或取代；R4表示氢或C1-C4烷基；A3表示C1-C4烷基、C2-C4烯基、>C═O、-C(O)C1-C3烷基、-C(═O)NH-或选择自-C2H4NH-、-C2H4O-和-C2H4S-的基团，通过碳原子与相邻的NR4基团相连；G表示未取代或取代的芳基或杂芳基，其中n为0、1或2；或其药学上可接受的盐、水合物或溶剂。这些化合物是有价值的抗菌剂。